Left atrial appendage occlusion for stroke prevention in atrial fibrillation in Europe: results of the European Heart Rhythm Association survey.

Percutaneous left atrial appendage occlusion for stroke prevention in atrial fibrillation: an update. Open Heart (2014) 1.06

Left atrial appendage closure to prevent stroke in patients with atrial fibrillation. Circulation (2014) 0.88

Percutaneous left atrial appendage occlusion - treatment outcomes and 6 months of follow-up - a single-center experience. Kardiochir Torakochirurgia Pol (2016) 0.75

Left Atrial Appendage: Physiology, Pathology, and Role as a Therapeutic Target. Biomed Res Int (2015) 0.75

Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J (2008) 8.20

Cardiovascular pre-participation screening of young competitive athletes for prevention of sudden death: proposal for a common European protocol. Consensus Statement of the Study Group of Sport Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology. Eur Heart J (2005) 6.93

2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). Eur Heart J (2013) 6.17

The 11th world survey of cardiac pacing and implantable cardioverter-defibrillators: calendar year 2009--a World Society of Arrhythmia's project. Pacing Clin Electrophysiol (2011) 2.99

Effect of long-detection interval vs standard-detection interval for implantable cardioverter-defibrillators on antitachycardia pacing and shock delivery: the ADVANCE III randomized clinical trial. JAMA (2013) 2.88

Reduced right ventricular ejection fraction in endurance athletes presenting with ventricular arrhythmias: a quantitative angiographic assessment. Eur Heart J (2007) 2.45

Inflammation in the genesis and perpetuation of atrial fibrillation. Eur Heart J (2005) 2.39

Incidence and etiology of sports-related sudden cardiac death in Denmark--implications for preparticipation screening. Heart Rhythm (2010) 2.34

Recommendations for competitive sports participation in athletes with cardiovascular disease: a consensus document from the Study Group of Sports Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology. Eur Heart J (2005) 2.29

How are arrhythmias managed in the paediatric population in Europe? Results of the European Heart Rhythm survey. Europace (2014) 2.01

[Takotsubo and surroundings. Step by step postpartum stress-induced cardiomyopathy shows its facet. A peculiar case of atypical takotasubo in the peripartum period]. G Ital Cardiol (Rome) (2014) 2.00

Clinical evaluation of defibrillation testing in an unselected population of 2,120 consecutive patients undergoing first implantable cardioverter-defibrillator implant. J Am Coll Cardiol (2012) 1.95

Risk of atrial fibrillation and stroke in rheumatoid arthritis: Danish nationwide cohort study. BMJ (2012) 1.94

Image integration increases efficacy of paroxysmal atrial fibrillation catheter ablation: results from the CartoMerge Italian Registry. Europace (2009) 1.93

A simplified biventricular defibrillator with fixed long detection intervals reduces implantable cardioverter defibrillator (ICD) interventions and heart failure hospitalizations in patients with non-ischaemic cardiomyopathy implanted for primary prevention: the RELEVANT [Role of long dEtection window programming in patients with LEft VentriculAr dysfunction, Non-ischemic eTiology in primary prevention treated with a biventricular ICD] study. Eur Heart J (2009) 1.89

Nationwide study of sudden cardiac death in persons aged 1-35 years. Eur Heart J (2010) 1.87

The prevalence of mutations in KCNQ1, KCNH2, and SCN5A in an unselected national cohort of young sudden unexplained death cases. J Cardiovasc Electrophysiol (2012) 1.65

Patients using vitamin K antagonists show increased levels of coronary calcification: an observational study in low-risk atrial fibrillation patients. Eur Heart J (2011) 1.60

The world survey of cardiac pacing and cardioverter-defibrillators: calendar year 2005 an International Cardiac Pacing and Electrophysiology Society (ICPES) project. Pacing Clin Electrophysiol (2008) 1.60

Plasma YKL-40, a new biomarker for atrial fibrillation? Europace (2009) 1.59

Deep sedation for catheter ablation of atrial fibrillation: a prospective study in 650 consecutive patients. J Cardiovasc Electrophysiol (2011) 1.55

How can optimization of medical treatment avoid unnecessary implantable cardioverter-defibrillator implantations in patients with idiopathic dilated cardiomyopathy presenting with "SCD-HeFT criteria?". Am J Cardiol (2011) 1.54

Patients originally diagnosed with idiopathic atrial fibrillation more often suffer from insidious coronary artery disease compared to healthy sinus rhythm controls. Heart Rhythm (2012) 1.53

Low disease prevalence and inappropriate implantable cardioverter defibrillator shock rate in Brugada syndrome: a nationwide study. Europace (2012) 1.53

[Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation]. G Ital Cardiol (Rome) (2009) 1.52

Current practice of ventricular tachycardia ablation in patients with implantable cardioverter-defibrillators. Europace (2012) 1.52

Recurrent vasovagal syncope: comparison between clomipramine and nitroglycerin as drug challenges during head-up tilt testing. Eur Heart J (2009) 1.48

Pharmacological and non-pharmacological therapy for arrhythmias in the pediatric population: EHRA and AEPC-Arrhythmia Working Group joint consensus statement. Europace (2013) 1.47

Clinical and arrhythmic outcomes after implantation of a defibrillator for primary prevention of sudden death in patients with post-myocardial infarction cardiomyopathy: The Survey to Evaluate Arrhythmia Rate in High-risk MI patients (SEARCH-MI). Europace (2009) 1.44

Sodium current and potassium transient outward current genes in Brugada syndrome: screening and bioinformatics. Can J Cardiol (2012) 1.43

KCNQ1 mutation Q147R is associated with atrial fibrillation and prolonged QT interval. Heart Rhythm (2007) 1.39

The effectiveness of a high output/short duration radiofrequency current application technique in segmental pulmonary vein isolation for atrial fibrillation. Europace (2006) 1.38

Comprehensive risk reduction in patients with atrial fibrillation: emerging diagnostic and therapeutic options--a report from the 3rd Atrial Fibrillation Competence NETwork/European Heart Rhythm Association consensus conference. Europace (2011) 1.35

Familial aggregation of atrial fibrillation: a study in Danish twins. Circ Arrhythm Electrophysiol (2009) 1.32

Adenosine testing after second-generation balloon devices (cryothermal and laser) mediated pulmonary vein ablation for atrial fibrillation. J Interv Card Electrophysiol (2014) 1.29

Impact of hybrid procedure on P wave duration for atrial fibrillation ablation. J Interv Card Electrophysiol (2015) 1.24

SCN1Bb R214Q found in 3 patients: 1 with Brugada syndrome and 2 with lone atrial fibrillation. Heart Rhythm (2011) 1.21

Update of the guidelines on sudden cardiac death of the European Society of Cardiology. Eur Heart J (2003) 1.21

Early echocardiographic deformation analysis for the prediction of sudden cardiac death and life-threatening arrhythmias after myocardial infarction. JACC Cardiovasc Imaging (2013) 1.20

Steerable versus nonsteerable sheath technology in atrial fibrillation ablation: a prospective, randomized study. Circ Arrhythm Electrophysiol (2011) 1.16

Minimal invasive surgery for atrial fibrillation: an updated review. Europace (2012) 1.16

Personalized management of atrial fibrillation: Proceedings from the fourth Atrial Fibrillation competence NETwork/European Heart Rhythm Association consensus conference. Europace (2013) 1.16

:Influence of the duration of Holter monitoring on the detection of arrhythmia recurrences after catheter ablation of atrial fibrillation: implications for patient follow-up. Int J Cardiol (2008) 1.15

2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing. Europace (2015) 1.13

A novel KCND3 gain-of-function mutation associated with early-onset of persistent lone atrial fibrillation. Cardiovasc Res (2013) 1.11

Risk stratification in individuals with the Brugada type 1 ECG pattern without previous cardiac arrest: usefulness of a combined clinical and electrophysiologic approach. Eur Heart J (2010) 1.10

KCNE3 mutation V17M identified in a patient with lone atrial fibrillation. Cell Physiol Biochem (2008) 1.09

J-shaped association between QTc interval duration and the risk of atrial fibrillation: results from the Copenhagen ECG study. J Am Coll Cardiol (2013) 1.08

Relation of 97T polymorphism in KCNE5 to risk of atrial fibrillation. Am J Cardiol (2005) 1.06

Atrial and ventricular volume and function evaluated by magnetic resonance imaging in patients with persistent atrial fibrillation before and after cardioversion. Am J Cardiol (2006) 1.06

[Takotsubo or peripartum cardiomyopathy? A challenging clinical dilemma]. G Ital Cardiol (Rome) (2014) 1.05

A novel nonsense variant in Nav1.5 cofactor MOG1 eliminates its sodium current increasing effect and may increase the risk of arrhythmias. Can J Cardiol (2011) 1.05

Risk of atrial fibrillation as a function of the electrocardiographic PR interval: results from the Copenhagen ECG Study. Heart Rhythm (2013) 1.03

Device-detected atrial tachyarrhythmias predict adverse outcome in real-world patients with implantable biventricular defibrillators. J Am Coll Cardiol (2011) 1.01

Atrial secretion of B-type natriuretic peptide. Eur Heart J (2006) 1.00

Long-term complications related to biventricular defibrillator implantation: rate of surgical revisions and impact on survival: insights from the Italian Clinical Service Database. Circulation (2011) 0.99

Surgical Ablation for Atrial Fibrillation. N Engl J Med (2015) 0.99

Validation of a novel automated border-detection algorithm for rapid and accurate quantitation of left ventricular volumes based on three-dimensional echocardiography. Eur J Echocardiogr (2009) 0.98

Current practice in transvenous lead extraction: a European Heart Rhythm Association EP Network Survey. Europace (2012) 0.98

ESC guidelines on management of acute myocardial infarction in patients presenting with persistent ST-segment elevation. Rev Esp Cardiol (2009) 0.97

Prospective multicenter randomized trial of fast ventricular tachycardia termination by prolonged versus conventional anti-tachyarrhythmia burst pacing in implantable cardioverter-defibrillator patients-Atp DeliVery for pAiNless ICD thErapy (ADVANCE-D) Trial results. J Interv Card Electrophysiol (2010) 0.97

Characterizations of a loss-of-function mutation in the Kir3.4 channel subunit. Biochem Biophys Res Commun (2007) 0.96

Recommendations for participation in leisure-time physical activity and competitive sports in patients with arrhythmias and potentially arrhythmogenic conditions Part I: Supraventricular arrhythmias and pacemakers. Eur J Cardiovasc Prev Rehabil (2006) 0.96

Severe tricuspid regurgitation due to entrapment of the anterior leaflet of the valve by a permanent pacemaker lead: role of real time three-dimensional echocardiography. Echocardiography (2007) 0.95

EnSite Velocity cardiac mapping system: a new platform for 3D mapping of cardiac arrhythmias. Expert Rev Med Devices (2010) 0.95

Sick sinus syndrome, progressive cardiac conduction disease, atrial flutter and ventricular tachycardia caused by a novel SCN5A mutation. Cardiology (2010) 0.95

Practices of cardiac implantable electronic device follow-up: results of the European Heart Rhythm Association survey. Europace (2012) 0.94

Patient satisfaction and suggestions for improvement of remote ICD monitoring. J Interv Card Electrophysiol (2012) 0.94

Current practice in Europe: how do we manage patients with ventricular tachycardia? European Heart Rhythm Association survey. Europace (2013) 0.94

Management of patients with palpitations: a position paper from the European Heart Rhythm Association. Europace (2011) 0.93

Catheter Ablation for Persistent Atrial Fibrillation. N Engl J Med (2015) 0.93

Prognostic impact of hs-CRP and IL-6 in patients with persistent atrial fibrillation treated with electrical cardioversion. Scand J Clin Lab Invest (2009) 0.92

Preferred tools and techniques for implantation of cardiac electronic devices in Europe: results of the European Heart Rhythm Association survey. Europace (2013) 0.92

Impact of emergency coronary angiography on in-hospital outcome of unconscious survivors after out-of-hospital cardiac arrest. Am J Cardiol (2012) 0.91

Tracing the European course of cardiac resynchronization therapy from 2006 to 2008. Europace (2010) 0.91

How European centres diagnose, treat, and prevent CIED infections: results of an European Heart Rhythm Association survey. Europace (2012) 0.90

Incidence and clinical relevance of uncontrolled ventricular rate during atrial fibrillation in heart failure patients treated with cardiac resynchronization therapy. Eur J Heart Fail (2011) 0.90

Missense variants in plakophilin-2 in arrhythmogenic right ventricular cardiomyopathy patients--disease-causing or innocent bystanders? Cardiology (2009) 0.90

Atrial fibrillation in chronic non-cardiac disease: where do we stand? Int J Cardiol (2008) 0.90

Management of malfunctioning and recalled pacemaker and defibrillator leads: results of the European Heart Rhythm Association survey. Europace (2014) 0.90

Electrical storm originating from a left ventricular epicardial scar in a patient with completely normal endocardial voltage. Heart Vessels (2011) 0.89

Current practice for diagnosis and management of silent atrial fibrillation: results of the European Heart Rhythm Association survey. Europace (2013) 0.89

Uncommon cause of ST-segment elevation in V1-V3: incremental value of cardiac magnetic resonance imaging. Clin Res Cardiol (2014) 0.88

Familial atrial fibrillation predicts increased risk of mortality: a study in Danish twins. Circ Arrhythm Electrophysiol (2012) 0.88

Prognostic impact of hs-CRP and IL-6 in patients undergoing radiofrequency catheter ablation for atrial fibrillation. Scand Cardiovasc J (2009) 0.87

Cardiac myotonic dystrophy mimicking arrhythmogenic right ventricular cardiomyopathy in a young sudden cardiac death victim. Circ Arrhythm Electrophysiol (2008) 0.87

Improving thromboprophylaxis using atrial fibrillation diagnostic capabilities in implantable cardioverter-defibrillators: the multicentre Italian ANGELS of AF Project. Circ Cardiovasc Qual Outcomes (2012) 0.87

Atrial and ventricular volume and function in persistent and permanent atrial fibrillation, a magnetic resonance imaging study. J Cardiovasc Magn Reson (2005) 0.87

Intrathoracic and ventricular impedances are associated with changes in ventricular volume in patients receiving defibrillators for CRT. Pacing Clin Electrophysiol (2009) 0.86